Literature DB >> 15983794

Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans.

Kathryn A Ellis1, Mitul A Mehta, Keith A Wesnes, Stuart Armstrong, Pradeep J Nathan.   

Abstract

RATIONALE: The mesocortical dopamine system is regarded as an important modulator of working memory. While it has been established that stimulation of the D1/D2 receptor in primates can improve spatial working memory performance, findings in humans are less consistent. Recent studies in humans suggest that global depletion of dopamine via tyrosine/phenylalanine depletion may impair spatial working memory performance, although these results are also inconsistent, and it has been suggested that task differences may partly underlie the inconsistent findings.
OBJECTIVES: This study had two aims: (1) to investigate the effects of acute tyrosine depletion (TPD) on a number of working memory tasks and (2) to examine whether stimulation of D1/D2 receptors under conditions of TPD can attenuate or "reverse" TPD-induced working memory impairments.
METHODS: Eighteen healthy male participants performed a spatial working memory delayed-recognition task, non-spatial working memory task and spatial n-back task on three separate occasions, after TPD, TPD and pergolide (D1/D2 agonist), and placebo.
RESULTS: TPD did not impair working memory performance on any of the tasks administered. However, stimulation of D1/D2 receptors under TPD conditions caused a subtle impairment in spatial working memory performance.
CONCLUSIONS: The finding that D1/D2 stimulation under TPD conditions impairs working memory highlights the complexity of functional effects of augmenting dopaminergic transmission within a dopamine-depleted state. The lack of TPD-related effects on a range of working memory tasks questions the reliability of TPD as a modulator of dopamine function and working memory performance in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983794     DOI: 10.1007/s00213-005-0019-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  63 in total

1.  Deterioration in parkinsonism with low-dose pergolide.

Authors:  M W Kellett; M J Steiger
Journal:  J Neurol       Date:  1999-04       Impact factor: 4.849

Review 2.  Catecholamine regulation of the prefrontal cortex.

Authors:  A F Arnsten
Journal:  J Psychopharmacol       Date:  1997       Impact factor: 4.153

3.  D1 dopamine receptors in prefrontal cortex: involvement in working memory.

Authors:  T Sawaguchi; P S Goldman-Rakic
Journal:  Science       Date:  1991-02-22       Impact factor: 47.728

4.  Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.

Authors:  J Kulisevsky; A Avila; M Barbanoj; R Antonijoan; M L Berthier; A Gironell
Journal:  Brain       Date:  1996-12       Impact factor: 13.501

5.  Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

Authors:  G V Williams; P S Goldman-Rakic
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

6.  Tyrosine depletion attenuates dopamine function in healthy volunteers.

Authors:  C J Harmer; S F McTavish; L Clark; G M Goodwin; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

7.  Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.

Authors:  M A Mehta; R Swainson; A D Ogilvie; J Sahakian; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2001-09-11       Impact factor: 4.530

8.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

9.  Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers.

Authors:  Mitul A Mehta; Facundo F Manes; Gianna Magnolfi; Barbara J Sahakian; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-04-28       Impact factor: 4.530

10.  Dopaminergic modulation of working memory for spatial but not object cues in normal humans.

Authors:  M Luciana; P F Collins
Journal:  J Cogn Neurosci       Date:  1997-05       Impact factor: 3.225

View more
  5 in total

1.  Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.

Authors:  Marco Leyton; Marije aan het Rot; Linda Booij; Glen B Baker; Simon N Young; Chawki Benkelfat
Journal:  J Psychiatry Neurosci       Date:  2007-03       Impact factor: 6.186

2.  Tyrosine depletion alters cortical and limbic blood flow but does not modulate spatial working memory performance or task-related blood flow in humans.

Authors:  Kathryn A Ellis; Mitul A Mehta; P J Naga Venkatesha Murthy; Sarah F B McTavish; Pradeep J Nathan; Paul M Grasby
Journal:  Hum Brain Mapp       Date:  2007-11       Impact factor: 5.038

3.  Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects.

Authors:  Andres H Neuhaus; Terry E Goldberg; Youssef Hassoun; John A Bates; Katharine W Nassauer; Serge Sevy; Carolin Opgen-Rhein; Anil K Malhotra
Journal:  Schizophr Res       Date:  2009-04-07       Impact factor: 4.939

4.  Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats.

Authors:  Remya Robinson; Amee Krishnakumar; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2009-01-09       Impact factor: 5.046

5.  Differential Effects of Pergolide and Bromocriptine on Working Memory Performance and Brain Activation after Mild Traumatic Brain Injury.

Authors:  Laura A Flashman; Brenna C McDonald; James C Ford; Rachel M Kenny; Katharine D Andrews; Andrew J Saykin; Thomas W McAllister
Journal:  J Neurotrauma       Date:  2020-08-10       Impact factor: 5.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.